Composition for the preservation of viruses

Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S093600, C514S558000

Reexamination Certificate

active

07091030

ABSTRACT:
This invention relates to a composition for the preservation of a virus, the composition including a virus, a lipid and a cryoprotectant.

REFERENCES:
patent: 4357324 (1982-11-01), Montgomery et al.
patent: 5122458 (1992-06-01), Post et al.
patent: 5561062 (1996-10-01), Varanelli et al.
patent: 5854224 (1998-12-01), Lockett et al.
patent: 5866551 (1999-02-01), Benoit et al.
patent: 5885590 (1999-03-01), Hunter et al.
patent: 5906922 (1999-05-01), Whittaker et al.
patent: 6017896 (2000-01-01), Sorscher et al.
patent: 6022530 (2000-02-01), Gers-Barlag et al.
patent: 6033885 (2000-03-01), Latta et al.
patent: 6066624 (2000-05-01), Woo et al.
patent: 6083720 (2000-07-01), Chroboczek et al.
patent: 6113913 (2000-09-01), Brough et al.
patent: 6124270 (2000-09-01), Haensler
patent: 6165779 (2000-12-01), Engler et al.
patent: 6218180 (2001-04-01), Kurtzman et al.
patent: 6225289 (2001-05-01), Kovesdi et al.
patent: 6749863 (2004-06-01), Chang et al.
patent: 2002/0045249 (2002-04-01), Both et al.
patent: 0 173 552 (1986-03-01), None
patent: 0 415 731 (1991-03-01), None
patent: 1 179 349 (2002-02-01), None
patent: 2 651 793 (1991-03-01), None
patent: 9-234069 (1997-09-01), None
patent: WO94/03594 (1994-02-01), None
patent: WO94/19478 (1994-09-01), None
patent: WO94/21792 (1994-09-01), None
patent: WO94/26914 (1994-11-01), None
patent: WO95/05835 (1995-03-01), None
patent: WO95/07718 (1995-03-01), None
patent: WO95/14091 (1995-05-01), None
patent: WO95/19434 (1995-07-01), None
patent: WO96/03508 (1996-02-01), None
patent: WO96/05218 (1996-02-01), None
patent: WO96/25506 (1996-08-01), None
patent: WO97/01358 (1997-01-01), None
patent: WO97/06826 (1997-02-01), None
patent: WO97/25339 (1997-07-01), None
patent: WO98/00524 (1998-01-01), None
patent: WO98/02522 (1998-01-01), None
patent: WO98/22144 (1998-05-01), None
patent: WO99/27073 (1999-06-01), None
patent: WO99/29710 (1999-06-01), None
patent: WO99/39740 (1999-08-01), None
patent: WO99/41416 (1999-08-01), None
patent: WO99/46385 (1999-09-01), None
patent: WO99/58156 (1999-11-01), None
patent: WO00/01418 (2000-01-01), None
patent: WO00/29024 (2000-05-01), None
patent: WO00/30687 (2000-06-01), None
patent: WO00/32233 (2000-06-01), None
patent: WO00/32754 (2000-06-01), None
patent: WO00/34444 (2000-06-01), None
patent: WO00/49147 (2000-08-01), None
patent: WO00/52156 (2000-09-01), None
patent: WO00/61141 (2000-10-01), None
patent: WO00/61605 (2000-10-01), None
patent: WO00/62815 (2000-10-01), None
patent: WO00/74723 (2000-12-01), None
patent: WO01/11066 (2001-02-01), None
patent: WO01/21217 (2001-03-01), None
patent: WO02/053183 (2002-07-01), None
Chillon M et al. 1998. Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Therapy 5: 995-1002.
Fasbender A et al. 1997. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem 272: 6479-6489.
Croyle, MA et al., Pharm Dev and Technol., vol. 3, 1998, pp. 373-383.
Liu, F. et al., Pharm Res., vol. 13, 1996, pp. 1856-1860.
Allison, SD et al., Arch Biochem Biophys., vol. 365, 1999, pp. 289-298.
Sudhanshu Vrati et al., Virology, vol. 220, 1996, pp. 200-203.
Linda J. Lockett et al., Virology, vol. 294, 2002, pp. 333-341.
D. Voeks et al., Gene Therapy, vol. 9, 2002, pp. 759-768.
Rosetta Martiniello-Wilks et al., Cancer Gene Therapy, vol. 9, 2002, pp. 443-452.
S. Dean Allison et al., Journal of Pharmaceutical Sciences, vol. 89, No. 5, May 2000, pp. 682-691.
T. Arakawa et al., Biochemistry, vol. 21, No. 25, 1982, pp. 6331-6618.
Michael W. Townsend et al., Journal of Parenteral Science and Technology, vol. 42, 1988, pp. 190-199.
Thomas M. Foster et al., International Journal of Pharmaceutics, vol. 134, 1996, pp. 193-201.
Sudhanshu Vrati et al., Virology, vol. 209, pp. 400-408, 1996.
Michael Petukhov et al., Protein Science, vol. 8, 1999, pp. 1982-1989.
Arno T. P. Skrabanja et al., PDA J. Pharm. Sci. Technol., vol. 48, No. 6, 1994, pp. 311-317.
Thomas Osterberg et al., Pharmaceutical Research, vol. 14, No. 7, 1997, pp. 892-898.
Henry R. Costantino et al., Journal of Pharmaceutical Sciences, vol. 87, No. 11, Nov. 1998, pp. 1412-1420.
Fiona H. Cameron et al., Bioch. Biophys. Acta, vol. 1417, 1999, pp. 37-50.
T. Lockett et al., Clinical and Exper. Pharm. and Phys., vol. 27, 2000, pp. 563-567.
DJ Voeks et al., Biotechniques, Jul. 2001, vol. 31, No. 1, pp. 46-49.
Lotte Kreilgaard et al., Journal of Pharmaceutical Sciences, vol. 88, No. 3, Mar. 1999, pp. 281-290.
Kunihiko Gekko et al., Biochemistry, vol. 20, 1981, pp. 4667-4676.
Harry Levine et al., Cryo-Letters, vol. 9, 1988, pp. 21-63.
Manohar Katakam et al., Journal of Pharmaceutical Sciences, vol. 84, No. 6, Jun. 1995, pp. 713-716.
Attar S. Chawla et al., Diabetes, vol. 34, 1985, pp. 420-424.
Kunio Takeda et al., Biochem. Biophys. Acta., vol. 957, 1988, pp. 340-344.
Jeffrey L. Cleland et al., Crit. Rev. Ther. Drug Carrier Syst., vol. 10, 1993, pp. 307-377.
G. Gonzalez et al., J. Colloid Interface Sci., vol. 32, 1970, pp. 55-61.
Pao-Li Wang et al., J. Parenter Sci. Technol., vol. 47, 1993, pp. 183-189.
Mark C. Manning et al., Pharmaceutical Research, vol. 6, No. 11, 1989, pp. 903-918.
Alexander V. Vologodskii et al., Annu. Rev. Biophys. Biomol. Struct., vol. 213, 1994, pp. 609-643.
Sergio Simoes et al., Current Opinion in Molecular Therapeutics, vol. 1, 1999, pp. 147-157.
T. Yamamoto, Can. J. Microbiol., vol. 13, 1967, pp. 1139-1149.
P. L. Stewart et al., pp. 25-38, 1995.
Thomas J. Anchordoquy et al., Journal of Pharmaceutical Sciences, vol. 87, No. 9, Sep. 1998, pp. 1046-1051.
Thomas J. Anchordoquy et al., Archives of Biochemistry and Biophysics, vol. 348, No. 1, Dec. 1, 1997, pp. 199-0206.
Bei Li et al., Journal of Pharm. Sciences, vol. 89, No. 3, Mar. 2000, pp. 355-364.
Feng Liu et al., Pharm. Research, vol. 13, No. 12, 1996, pp. 1856-1860.
Michael J. Pikal et al, BioPharm, vol. 3, Oct. 1990, pp. 26-30.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Composition for the preservation of viruses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for the preservation of viruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for the preservation of viruses will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3710693

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.